NB

Nikulbhai Bholabhai Vasoya

Active Director Designated Partner DIN 10674702
DIN 10674702 First appointment Jun 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nikulbhai Bholabhai Vasoya

Data last updated:

Nikulbhai Bholabhai Vasoya is a Designated Partner at Critilife Pharma Llp (since 2024).

DIN 10674702
Primary Designation Designated Partner
First Appointment 19 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Jun 20242024Active

Board colleagues of Nikulbhai Bholabhai Vasoya

NameDINCompanyDesignation
Avinash Pragajibhai Marakana10674703Critilife Pharma LlpDesignated Partner
Vikas Arvindbhai Akabari10674704Critilife Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Critilife Pharma Llp
Premium access

Shareholding and investment profile for Nikulbhai Bholabhai Vasoya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikulbhai Bholabhai Vasoya

Nikulbhai Bholabhai Vasoya currently holds 1 directorship: Critilife Pharma Llp (Designated Partner, since 19 Jun 2024).

Nikulbhai Bholabhai Vasoya was first appointed on 19 Jun 2024 as Designated Partner at Critilife Pharma Llp.

The current boards of Nikulbhai Bholabhai Vasoya's companies include Avinash Pragajibhai Marakana (Critilife Pharma Llp), Vikas Arvindbhai Akabari (Critilife Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available